Skip to main content
Caplight Logo









Astraveus

Astraveus

Private
ParisHealthcare & Life Scienceshttps://www.astraveus.com/

Last Round

Grant

Dec 19, 2024

Total Funding Raised

$36.72M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Astraveus is a biotechnology company that develops the Lakhesys™ platform, a benchtop cell factory for the automated and miniaturized manufacturing of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

CGT manufacturingmicrofluidic manufacturingcell therapy automationcell and gene therapybenchtop cell factorymicrofluidicssingle-use bioprocessorsfactory-in-a-boxCAR-T manufacturingbioprocessingbiotech equipmentGMPgood manufacturing practiceCDMOcontract development and manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astraveus Comparables

Compare Astraveus with similar companies based on industry and business-model similarity.

Astraveus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ori Biotech
89%
Limula
86%
Adva Biotechnology
85%

Astraveus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 19, 2024
GrantOct 24, 2023
SeedJun 27, 2023

Key People

Founding team and executive leadership

Ken Kotz

Chief Technology Officer

Executive Team

Didier Masson

Chief Operating Officer

Executive Team

Astraveus Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 31, 2.3x the trailing average.

  • May 13, 2025

    Grew 19% QoQ, from 53 to 63 employees.

Astraveus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Astraveus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Astraveus's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range66
Year Founded2016
Last FundingDec 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?